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Editors: Anton N. Sidawy and Bruce A. PerlerPredictors and outcome of endoleaks in the Veterans
Affairs Open Versus Endovascular Repair (OVER) Trial of
Abdominal Aortic Aneurysms
Brajesh K. Lal, MD, Wei Zhou MD, Ziyi Li, MPH, Tassos
Kyriakides, PhD, Jon Matsumura, MD, Frank A. Lederle, MD,
and Julie Freischlag, MD, for the OVER Veterans Affairs
Cooperative Study Group
Objective: The Veterans Affairs Open Versus Endovascular
Repair (OVER) Trial of Abdominal Aortic Aneurysms
study was a randomized controlled trial comparing open
vs endovascular repair (EVAR) in standard-risk patients
with infrarenal aortic aneurysms. The analysis reported here
identiﬁes characteristics, risk factors, and long-term out-
come of endoleaks in patients treated with EVAR in the
OVER cohort.
Methods: The OVER trial enrolled 881 patients, of whom
439 received successful EVAR. Logistic regression analysis
was used to identify predictors for endoleaks and secondary
interventions. Kaplan-Meier survival analysis, longitudinal
plots, and generalized linear mixed models methods were
used to describe time to endoleak detection, resolution, or
death.
Results: During a mean follow-up of 6.2  2.4 years, 135
patients (30.5%) developed 187 endoleaks. Four patients
with EVAR went on to rupture; these four patients did not
all have an endoleak. Mortality between patients who did
and did not develop endoleaks was not signiﬁcantly differ-
ent. The 187 endoleaks included 12% type I, 76% type II,
3% type III, 3% type IV, and 6% indeterminate. Patient
demographics and vascular risk factors were not associated
with endoleak development. The presence of endoleaks
resulted in an increase in aneurysm diameter over time (P<
.0001). Fifty-three percent of endoleaks resolved sponta-
neously, and 31.9% received secondary interventions. The
initial aneurysm size independently predicted a need
for secondary interventions (P < .0003). Delayed type
II endoleaks (detected >1 year after EVAR) were associated
with aneurysm enlargement compared with the early
counterpart. There was no difference in aneurysm size or
length of survival between type II and other types of
endoleak.
Conclusions: We present one of the most comprehensive
and longest follow-up analyses of patients treatedwith aortic
endografts. Endoleaks were common and negatively affected
aneurysm diameter reduction. Delayed type II endoleaks*Full articles available online at www.jvascsurg.org
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http://dx.doi.org/10.1016/S1078-5884(15)00812-6were associated with late aneurysm diameter enlargement.
Endoleaks and aneurysm diameter enlargement were not
associated with excess mortality compared with those
without these features.Postoperative renal dysfunction independently predicts
late mortality in patients undergoing aortic reconstruction
Virendra I. Patel, MD, MPH, Robert T. Lancaster, MD, MPH,
Emel Ergul, MS, Mark F. Conrad, MD, MSSc, Daniel Bertges,
MD, Marc Schermerhorn, MD, Philip Goodney, MD, and
Richard P. Cambria, MD
Objective: Preoperative chronic kidney disease (CKD) has
been shown to predict postoperative renal complications
and mortality after open aortic surgery; the impact of
postoperative renal complications less severe than perma-
nent dialysis are unknown. We evaluated the impact of
postoperative renal dysfunction severity on survival using a
regional quality improvement registry.
Methods: Patients undergoing intact open aortic recon-
struction in the Vascular Study Group of New England
registry (2003-2012) were stratiﬁed by severity of post-
operative renal complications; none, creatinine increase of
greater than 0.5 mg/dL (incCr), or any hemodialysis (HD).
Predictors of renal dysfunction and impact of renal com-
plications on survival were analyzed using multivariable
methods.
Results: We included 2695 patients, of which 65%
(n ¼ 1733) underwent open abdominal aortic aneurysm
repair, and 35% (n ¼ 962) open aortoiliac reconstruction. At
baseline, 15% of patients had preoperative moderate CKD
and 1.2% had severe CKD. Postoperative renal complica-
tions of incCr occurred in 8.5% of patients, and 1.5%
required HD. Multivariable cumlogit regression identiﬁed
severe baseline CKD (odds ratio [OR], 15; 95% conﬁdence
interval [CI], 6.4-34; P < .001, moderate CKD (OR, 2.8; 95%
CI, 1.9-3.3; P < .001), suprarenal clamp use (OR, 2.2; 95% CI,
1.6-2.9; P < .001), perioperative vasopressor requirements
(OR, 2.2; 95% CI, 1.6-2.9; P < .001), operating time (OR,
1.004 per minute; 95% CI, 1.003-1.006; P < .001), and
chronic obstructive pulmonary disease (OR, 1.5; 95% CI, 1.2-
1.8; P < .001) as independent predictors of worsening strata
of postoperative renal dysfunction. Multivariable logistic
regression analysis showed that patient age (OR, 1.06 per
year; 95% CI, 1.01-1.1; P ¼ .01), baseline chronic obstructive
pulmonary disease (OR, 1.6; 95% CI, 1.2-2.2; P < .01), incCr
(OR, 3.7; 95% CI, 1.8-7.4; P ¼ .009), and HD (OR, 4.8; 95% CI,
1.8-12.7); P ¼ .009) independently increased 30-day
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showed that incCr (hazard ratio, 1.8; 95% CI, 1.3-2.6; P <
.001) and HD (hazard ratio, 4.4; 95% CI, 2.8-6.9; P < .001)
increased risk of late death independent of a variety of
other clinical variables, including baseline CKD. The 5-year
survival was lower (log-rank P < .001) in patients with incCr
(66%  4%), and HD (38%  10%) compared with those
with no renal complications (77%  1%).
Conclusions: Increasing severity of postoperative renal
dysfunction independently predicts increased risk of late
mortality after open aortic surgery. Perioperative measures
to decrease renal complications may potentially prolong the
survival of patients after open aortic surgery.The in-hospital costs of treating high risk patients with
fenestrated and branched endografts
Elrasheed Osman, FRCSI, Kong T. Tan, MD, Leonard Tse, MD,
Jeffrey Jaskolka, MD, Graham Roche-Nagle, MD, George
Oreopoulos, MD, Barry Rubin, MD, and Thomas Lindsay, MD
Objective: This study determined the 30-day morbidity and
mortality and in-hospital costs of elective fenestrated
(fEVAR) and branched (bEVAR) endovascular aneurysm
repairs at a single academic institution and determined
factors that inﬂuence them.
Methods: All elective fEVAR or bEVAR patients treated
between November 2007 and March 2014 in a Canadian
academic hospital were included. Procedural details, 30-day
morbidity and mortality rates, and cost of hospitalization
were analyzed. Nonparametric bootstrap analysis was used
to compare means between groups and calculate con-
ﬁdence intervals (CIs).
Results: There were 84 consecutive fEVAR (n ¼ 61) and
bEVAR (n ¼ 23) procedures. The 30-day mortality was 3.3%
for fEVAR and 4.3% for bEVAR. Mean hospital stay was
7.2  0.8 days for fEVAR and 12.6  2.2 days for bEVAR.
The mean cost of the index hospitalization was $57,000 for
fEVAR and $91,000 for bEVAR. Device-related costs
accounted for 55% of the total costs. The occurrence of
intraoperative or postoperative events were used to further
divide each of the fEVAR and bEVAR groups
into “complicated hospitalization” (fEVAR, n ¼ 10; bEVAR,
n ¼ 13) and “uncomplicated hospitalization” (fEVAR,
n ¼ 51; bEVAR, n ¼ 10) groups. Device-related costs were
not signiﬁcantly different between the complicated and
uncomplicated hospitalization groups (mean difference
[95% CI] fEVAR: $3383 [$3405 to $9809], P ¼ .3; and
bEVAR: $1930 [$7892 to $11,288], P ¼ .68). However,
there were signiﬁcant differences between the complicated
and uncomplicated hospitalization groups in hospital length
of stay (mean difference [95% CI] fEVAR: 8.1 [3.0-13.2] days,
P ¼ .001; and bEVAR: 10.8 [5.9-19.9] days, P ¼ .002) and
nondevice-related costs (mean difference [95% CI,] fEVAR:
$25,843 [$11,689-$43,247], P ¼ .001; and bEVAR; $20,326
[$9362-$36,615], P ¼ .002).
Conclusions: bEVAR and fEVAR are expensive interventions.
Intraoperative adverse events and postoperative systemiccomplications dramatically increase costs and length of stay.
Measures to minimize complications will reduce hospital-
ization costs and improve patient outcomes.Comparison of posterior and medial approaches for
popliteal artery aneurysms
Daniela Mazzaccaro, MD, Michele Carmo, MD, Raffaello
Dallatana, MD, Alberto M. Settembrini, MD, Iacopo
Barbetta, MD, Luca Tassinari, MD, Sergio Roveri, MD, and
Piergiorgio G. Settembrini, MD
Background: Long-term results of the posterior approach
(PA) for the treatment of popliteal artery aneurysms are
lacking in the literature. We reviewed our experience dur-
ing a 13-year period in patients with popliteal artery
aneurysms, comparing those treated through a PA with
those operated on through a standard medial approach
(MA).
Methods: Clinical data of all patients treated between
February 1998 and October 2011 were retrospectively
reviewed and outcomes analyzed. The Kaplan-Meier
method was used to estimate survival, and c2, Wilcoxon,
and log-rank tests were used for analysis.
Results: A total of 77 aneurysms were treated in 65 patients
(64 men). Mean age was 68 years (range, 48-96 years).
Thirty-six aneurysms were asymptomatic (47%). Mean sac
diameter was 2.8  1 cm. A PA was used in 43 PAAs (55%)
and an MA in 34. The PA and MA patients differed sig-
niﬁcantly in age (median being older), smoking history
(more frequent in PA), and renal insufﬁciency and cere-
brovascular disease (higher for MA). In 42 cases the
aneurysm was symptomatic (54.5%) for chronic limb
ischemia, with intermittent claudication in 18 patients,
acute ischemia in 17, blue toe syndrome in 3, compression
on adjacent structures in 3, and rupture with severe acute
pain in 1. All PA repairs consisted of aneurysmectomy with
an interposition graft with end-to-end anastomoses; among
MA repairs, 22 interposition grafts and 12 bypasses were
performed. A polytetraﬂuoroethylene graft was used in 54
cases. Five patients had an early thrombosis (two PA and
three MA). No perioperative deaths occurred. Two patients
sustained a permanent (PA) and a temporary (MA) peroneal
nerve lesion. There were no early amputations. The median
in-hospital stay was longer for MA (10 days) than for PA (7
days; P ¼ .02). Median follow-up was 58.8 months (range, 5
days-166 months). Nine patients died during follow-up of
unrelated causes. The 5-year primary and secondary
patency rates were 59.6%  8.6% and 96.5%  3.4%,
respectively, for PA, and 65.1%  11.1% and 79.4%  9.7%,
respectively, for MA (P ¼ .53 for primary patency rate and
P ¼ .22 for secondary patency rate). Limb salvage was 100%
at 5 years and 93.3%  6.4% at 10 years for PA and 91.1% 
6.3% at both time points for MA (P ¼ .28).
Conclusions: PA and MA both achieved satisfactory results
in primary and secondary patency rates, as well as limb
salvage, during long-term follow-up. The differences
between the two groups were small and not statistically
834 Abstractssigniﬁcant. PA was burdened by similar postoperative nerve
and wound complications compared with MA. The in-hos-
pital stay after PA was signiﬁcantly lower.Urgent carotid intervention is safe after thrombolysis for
minor to moderate acute ischemic stroke
Hernan A. Bazan, MD, FACS, Nicolas Zea, MD, Bethany
Jennings, RN, Taylor A. Smith, MD, FACS, Gabriel Vidal, MD,
and W. Charles Sternbergh III, MD, FACS
Objective: Carotid intervention shortly after an acute neu-
rologic ischemic event is being performed more frequently
in stroke centers to reduce the risk of recurrent stroke.
Thrombolysis with recombinant tissue plasminogen activa-
tor (tPA) is offered to select patients with ischemic stroke
symptoms who present within 4.5 hours. However, there is
a paucity of data as to whether tPA followed by urgent
carotid endarterectomy (CEA) or carotid artery stenting
(CAS) has an increased risk of complications, particularly
intracerebral hemorrhage (ICH). We sought to determine
the periprocedural complications of urgently performed
CEA or CAS following tPA.
Methods: From January 2009 to January 2015, 762 patients
underwent carotid interventions (CEA, n ¼ 440; CAS, n ¼
322) at a tertiary referral center and 165 patients (21.6%)
underwent an urgent CEA or CAS during the index hospi-
talization for an acute transient ischemic attack or stroke.
We compared the effect of intravenous tPA on 30-day
complications, including ICH. The c2 and Fisher exact tests
were used to determine signiﬁcance between groups.
Results: During the 6-year period, 165 patients underwent
urgent carotid interventions (CEA, n ¼ 135; CAS, n ¼ 30) for
acute neurologic symptoms. Of these, 19% (31 patients
[CEA, n ¼ 25; CAS, n ¼ 6]) had tPA for an acute stroke; the
remaining (134 patients [CEA, n ¼ 110; CAS, n ¼ 24]) fell
outside of the tPA time window. Most strokes were minor
or moderate with a mean National Institutes of Health
Stroke Scale (NIHSS) score of 6.6 (range, 0-19). The mean
time to intervention for both groups was 2.4 days (0-15
days). The 30-day stroke, death, and myocardial infarction
rates were 9.7% (3 of 31) for the tPA group compared with
4.5% (6 of 134) for the no-tPA group (P ¼ .37). Including
bleeding complications in these 30-day outcomes, there
was no difference between the tPA (3 of 31) and the no-tPA
cohorts (8 of 134; P ¼ .43). In the tPA group, there were one
ICH, one neck hematoma/death, and an additional death; in
the no-tPA group, there were one ICH, two neck hema-
tomas, one stroke, two myocardial infarctions, one ICH/
death, and one additional death. No signiﬁcant increased
rates of bleeding were noted within the tPA group (2 of 31)
compared with the no-tPA group (4 of 134; P ¼ .32).
Moreover, in the tPA cohort, more than half of the patients
(17 of 31) underwent revascularization within 72 hours (CEA
¼ 13; CAS ¼ 4) with outcomes similar to those who
underwent revascularization after 72 hours.Conclusions: Thrombolysis followed by urgent CEA or CAS is
not associated with an increased risk of complications in
select patients who present with acute neurologic symp-
toms. Selection of patients is important; there was no ICH
and only one death in each group for patients with minor to
moderate ischemic stroke (NIHSS score <10).A randomized controlled trial of interrupted versus
continuous suturing techniques for radiocephalic ﬁstulas
Emma Aitken, MBChB (Hons), MRCS, Eddie Jeans, MBChB,
MRCS, Margaret Aitken, RGN, and David Kingsmore, MD,
FRCS
Objective: Continuous suturing techniques have conven-
tionally been used for the end-to-side anastomoses of
radiocephalic ﬁstulas (RCFs); however, primary patency
rates are poor. Only 50% to 60% of RCFs ever achieve
functional patency. We hypothesized that a hybrid inter-
rupted-continuous suturing technique (as used in many
microsurgical procedures) may improve outcomes in ﬁstulas
constructed from small vessels.
Methods: A randomized controlled trial comparing hybrid
interrupted continuous (n ¼ 42) with continuous (n ¼ 36)
suturing techniques for RCF was undertaken. Patients were
excluded if vessels were <1.8 mm in diameter or if previous
ipsilateral ﬁstula had been attempted. A priori power cal-
culation indicated that a sample size of 78 patients was
required to detect an improvement in patency from 50% to
80% (a ¼ .05, b¼ .8). The primary end point was primary
patency at 6 weeks (assessed by a blinded observer for the
presence of thrill and bruit). Secondary end points were
immediate patency, functional patency (assessed clinically
and by ultrasound) at 6 weeks, and presence of anastomotic
stenosis.
Results: Groups were comparable for basic patient demo-
graphics, operating surgeon, and vessel diameter asmeasured
on preoperative ultrasound (mean age, 58.9 13 years; 68%
male). Primary patency at 6 weeks was higher in the hybrid
interrupted-continuous suturing technique group (71% vs
47%; P ¼ .01). Immediate patency was also higher in the
hybrid interrupted-continuous suturing technique group (93%
vs 67%; P < .001). There was no signiﬁcant difference
in functional patency at 6 weeks (52% vs 36%; P¼ .18). Three
patients developed an anastomotic stenosis. All were in the
hybrid interrupted-continuous suturing technique group. One
patient from the interrupted suturing technique cohort
required re-exploration for bleeding.
Conclusions: A hybrid interrupted-continuous suturing
technique yielded higher immediate and 6-week primary
patency rates for RCF. The hybrid interrupted-continuous
suturing technique may improve anastomotic compliance
and reduce the narrowing and puckering that can occur on
suture tightening in small-caliber vessels. Based on these
ﬁndings, consideration should be given to performing
hybrid interrupted-continuous anastomoses for RCFs.
